etofenamate

Also known as BAY-D-1107, WHR-5020, SID11112716, TVX-485, SID144204169

Etofenamate is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of joint and muscular pain. It is available for topical application as a cream, a gel or as a spray.

In the Vinony graph

Within Vinony's link graph, etofenamate is referenced by 283 other articles, and connects out to salicylic acid, non-steroidal anti-inflammatory drug and metamizole sodium.

Vinony files it under 3-(Trifluoromethyl)phenyl compounds, Anthranilates and Drugs with non-standard legal status.

Its subject is documented across 14 Wikipedia language editions.

Research

120 papers

Clinical Efficacy and Safety Profile of Topical Etofenamate in the Treatment of Patients with Musculoskeletal Disorders: A Systematic Review.Pain and therapy · 2020
Efficacy and Safety of an Etofenamate Medicated Plaster for Acute Ankle Sprain: A Randomized Controlled Trial.Orthopaedic journal of sports medicine · 2021
Allergic contact dermatitis from etofenamate without cross-sensitization to other anthranilic acid derivatives.Dermatology (Basel, Switzerland) · 2003
[Allergic contact eczema to etofenamate and dwarf pine oil].Sportverletzung Sportschaden : Organ der Gesellschaft fur Orthopadisch-Traumatologische Sportmedizin · 1990
Effectiveness of etofenamate for treatment of knee osteoarthritis: a randomized controlled trial.Therapeutics and clinical risk management · 2016

via PubMed

Wikidata facts

Mass: 369.118793

Show 3 more facts

chemical formula: C₁₈H₁₈F₃NO₄
canonical SMILES: C1=CC=C(C(=C1)C(=O)OCCOCCO)NC2=CC=CC(=C2)C(F)(F)F
Commons category: Etofenamate

Sources (2)

via Wikidata · CC0

~1 min read

Encyclopedic overview

1 sections

Contents

References

Etofenamate is a nonsteroidal anti-inflammatory drug (NSAID) used for the treatment of joint and muscular pain. It is available for topical application as a cream, a gel or as a spray.

Etofenamate is very toxic to aquatic life, with long lasting effects.

Excerpted from Wikipedia’s “etofenamate” article, available under the CC BY-SA 4.0 licence.